oid_c2e0f1c5-94dd-ef11-a72f0022489e9131_Recursion Logo Horizontal Black@4x.png 1

Recursion

Drug Discovery

  • Funding stage: Not applicable
  • Technology type: Tech Bio
Phone
+13852690203
Membership category
Corporate Technology

3, Pancras Sq, London, N1C 4AG, United Kingdom

Recursion at a glance

Decoding biology to radically improve lives

About Recursion

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.

Therapeutic area(s)

Articles Recursion has contributed to